Myris Therapeutics
  • HOME
  • COMPANY
    • ABOUT
    • OUR TEAM
    • SCIENTIFIC PUBLICATIONS
  • NEWS
  • CONTACT
Select Page

Better Protein-Polymer Hybrids

by Jason Anthony | Oct 1, 2016 | News

Biohybrid Solutions™ is pioneering a new approach to bioconjugate production using polymer-based protein engineering. This innovation allows more control, expands the available polymer library, and minimizes the issues inherent with attaching polyethylene glycol (PEG)...

Recent Posts

  • Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
  • BioHybrid Solutions Holdings, Inc. Announces Expansion of its Drug Development Leadership  
  • BioHybrid Solutions Holdings, Inc. Appoints Mark Murcko as Board Member
  • BioHybrid Solutions™ announces the formation of its Holdings Corporation and Subsidiaries
  • BioHybrid Solutions™ Announces Jean Pineault as President and Chief Executive Officer

Recent Comments

    Archives

    • February 2025
    • June 2023
    • September 2022
    • May 2022
    • January 2022
    • December 2019
    • November 2019
    • April 2017
    • November 2016
    • October 2016
    Copyright © Myris Therapeutics